![]() |
市场调查报告书
商品编码
1827705
2025年全球骨质密度检测设备市场报告Bone Densitometer Global Market Report 2025 |
近年来,骨质密度检测设备市场规模强劲成长,从2024年的13.5亿美元增加至2025年的14.5亿美元,复合年增长率为7.2%。预测期内的成长可归因于人口老化、人们对骨骼健康重要性的认识不断提高、医疗基础设施的完善以及经济成长。
预计未来几年骨质密度检测设备市场将快速成长,到2029年将达到21.7亿美元,复合年增长率为10.7%。预测期内的成长归因于预防性医疗保健的增加、研发的活性化、医疗保健支出的增加以及骨质疏鬆症盛行率的上升。预测期内的主要趋势包括人工智慧 (AI) 整合、永续性和绿色技术、可穿戴骨骼健康监测、患者参与解决方案以及远端监控。
骨质密度检测设备是一种用于测量骨骼密度的医疗设备,它提供有关骨骼健康的重要资讯。骨质密度检测设备常用于医院和诊断中心,它使用先进的X射线技术来评估骨骼的矿物学和密度。
主要的骨质密度检测设备类型包括 DXA 系统 (双能量 X 射线检测法)、周边骨骨密度仪、X 射线吸收扫描仪和定量超音波扫描仪。 DXA 系统是用于测量骨骼密度的先进 X 光技术。该技术使用极少量的电离辐射来产生身体内部影像,有助于评估骨质流失。骨质密度检测设备用于各种医疗保健场所,包括医院、诊所、诊断中心和影像中心。它们可用于诊断骨质疏鬆症、骨质缺乏症和类风湿性关节炎等疾病,以及测量身体组成。
2025年春季,美国关税突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战进一步加剧了形势,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场准入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司(The Business Research Company)新报告系列的一部分,该系列提供骨质密度检测设备市场统计数据,包括全球市场规模、各地区市场份额、骨质密度检测设备市场份额竞争对手、详细的骨质密度检测设备细分市场、市场趋势和商业机会,以及在骨质密度检测设备行业取得成功所需的数据。本骨质密度检测设备骨质密度检测设备研究报告提供了全面的市场展望,并对行业现状和未来趋势进行了详细分析。
我们对该市场未来五年10.7%的成长率预测与先前保持不变。下滑的主要原因是美国与其他国家之间关税的影响。这种影响可能会直接波及美国,导致双能量X射线吸收仪(DEXA)组件和精密校准模型的供应链中断,这些组件和模型主要来自日本和瑞士等主要地区,这可能导致骨质疏鬆症诊断延迟,并增加医疗机构的资本成本。由于互惠关税以及贸易紧张局势和限制措施升级对全球经济和贸易的负面影响,这种影响也可能更为广泛。
骨质疏鬆症的日益普及预计将推动对骨质密度检测设备的需求。骨质疏鬆症的特征是骨骼密度和强度下降,导致骨质脆弱,可归因于低钙摄取、遗传性疾病和胃肠手术等因素。骨质密度检测设备在透过特定技术和应用计算定量骨骼密度方面发挥关键作用,有助于骨质疏鬆症的诊断和治疗。根据安进公司在 2022 年的报告,估计每年有 150 万美国人经历与骨质疏鬆症相关的骨折,花费 190 亿美元,推动了对骨质密度检测设备的需求。全球骨质疏鬆症患者的增加预计将推动骨质密度检测设备市场的成长。
预计未来几年,老龄化人口的成长将推动骨质密度检测设备市场的扩张。 「老化」是指老年人在总人口中所占比例或百分比的不断增加。老化影响着全球经济、医疗保健系统和社会支持网络。老年人更容易患骨质疏鬆症,这凸显了早期发现和预防的必要性,以及骨骼健康的重要性及其对医疗保健的影响。骨骼密度测量是诊断和治疗老年人骨质疏鬆症的重要方法,有可能降低医疗成本并改善患者的预后。例如,根据美国皮尤研究中心2024年1月发布的报告,预计2024年老龄人口将达到10.1万人,到2054年将增加至42万人。因此,老龄化人口的成长正在推动骨质密度检测设备市场的成长。
技术进步是骨质密度检测设备市场的一个突出趋势,主要企业正专注于提供先进的解决方案以满足客户趋势并提升其市场地位。公司正在将下一代技术(如放射照相术、电脑断层扫描、萤光透视、乳房X光摄影、衍射、 3D 视觉化和建模)融入他们的骨质密度检测设备产品中。例如,义大利医疗设备製造商 Echolight SPA 使用射频回波多光谱 (REMS) 技术提供一种创新的无辐射骨骼密度解决方案。 REMS 技术克服了 DXA 和 QUS 等传统技术的局限性,提供了一种无辐射方法来评估腰椎和颈部的骨骼状态。这种对技术创新的重视正在推动骨质密度检测设备市场的发展。
骨质密度检测设备市场的主要参与企业正在进行策略性投资以增强其能力,例如苏黎世州银行对 MEDIMAPS GROUP 的投资。苏黎世州银行向 Medimaps Group 进行了 2000 万美元的大额投资,Medimaps Group 是一家瑞士影像处理软体提供商,专门使用常规医学影像进行骨骼健康评估。这项投资透过苏黎世州银行的资产管理部门 Swiss KantInvest 进行。瑞士企业家基金、Swisscom Ventures 和 Verve Ventures 也参与了由 Swiss KantInvest主导的此轮资金筹措。 2021 年 12 月,Medimaps Group 宣布已成功从机构投资者手中资金筹措2,000 万美元。这笔资金旨在支持使用常规医学影像进行骨骼健康评估的人工智慧产品组合的开发和商业化。这些资金将用于开发和推出用于骨骼健康评估的专有 AI 应用程序,并扩展其在美国、欧洲、亚洲和拉丁美洲的产品线。
2022年4月,美国社区医院纽曼区域医疗中心 (Newman Regional Health) 与豪洛捷 (Hologic) 达成合作,将 Horizon DXA骨骼密度仪系统纳入其医疗服务。此次策略伙伴关係使纽曼区域医疗中心能够提升其为男性和女性提供的健康和福祉服务。 Horizon DXA 系统由美国诊断产品、医学影像系统和外科产品製造商和供应商 Hologic 开发,采用先进的成像技术,可提供卓越的影像品质和尖端的诊断工具。该系统支持骨质疏鬆症的早期发现和治疗,有助于改善患者的医疗效果。
骨质密度检测设备市场上的一些主要企业包括 Diagnostic Medical Systems SA、GE Healthcare Technologies Inc.、Hologic Inc.、BeamMed Ltd.、Demetech AB、Osteometer Meditech Inc.、OSTEOSYS Corp.、Trivitron Healthcare Private Limited、Swissray International Inc.、MEDIao Healthcare Medical Ltd.、Xingao Global Etquid Limited、Swissray International Inc.、MEDIao Global Ltd.、Xingao Global Et. AB、Medonica Co.Ltd.、CyberLogic Inc.、Oscare Medical Oy、L'Acn Srl.、深圳艾克瑞电气有限公司、YOZMA BMTech Co.Ltd.、Nanoomtech Co.Ltd.、Nanoomtech Co.Ltd.、MedANNSaboratories Inc.、Stemon Inc. Corporation、Koninklijke Philips NV 和 Samsung Medison Co. Ltd.。
2024年骨质密度检测设备市场最大的地区是北美。预计亚太地区将成为预测期内成长最快的地区。骨质密度检测设备市场报告涵盖的地区包括亚太地区、西欧、中欧和东欧、北美、南美以及中东和非洲。
骨质密度检测设备市场报告涉及的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国和美国。
骨质密度检测设备市场包括中央DEXA和周边DEXA的销售。该市场的价值是「工厂门口」价值,即商品製造商或生产商销售给其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接销售给最终客户的商品价值。该市场中的商品价值还包括商品製造商销售的任何相关服务。
A bone densitometer is a medical device designed to measure bone mineral density, providing crucial information about the health of bones. Typically utilized in hospitals and diagnostic centers, a bone densitometer employs advanced X-ray technology to assess the minerals and density of bones.
Key types of bone densitometers include DXA systems (dual-energy X-ray absorptiometry), peripheral bone densitometers, radiographic absorptiometry scanners, and quantitative ultrasound scanners. DXA systems, in particular, represent an advanced form of X-ray technology used to measure bone mineral density. This technology employs a minimal dose of ionizing radiation to generate images of the inside of the body, aiding in the assessment of bone loss. Bone densitometers find application in various healthcare settings, including hospitals, clinics, diagnostic and imaging centers. They are instrumental in diagnosing conditions such as osteoporosis, osteopenia, rheumatoid arthritis, and for measuring body composition.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The bone densitometer market research report is one of a series of new reports from The Business Research Company that provides bone densitometer market statistics, including bone densitometer industry global market size, regional shares, competitors with a bone densitometer market share, detailed bone densitometer market segments, market trends and opportunities, and any further data you may need to thrive in the bone densitometer industry. This bone densitometer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The bone densitometer market size has grown strongly in recent years. It will grow from $1.35 billion in 2024 to $1.45 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to aging population, rise in awareness about the importance of bone health, rise in healthcare infrastructure, economic growth.
The bone densitometer market size is expected to see rapid growth in the next few years. It will grow to $2.17 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to rise in preventive healthcare, rising research and development, rising healthcare spending, increasing prevalence of osteoporosis. Major trends in the forecast period include artificial intelligence (ai) integration, sustainability and green technology, wearable bone health monitoring, patient engagement solutions, remote monitoring.
The forecast of 10.7% growth over the next five years remains unchanged from the previous projection for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for dual-energy X-ray absorptiometry (DEXA) components and precision calibration phantoms, sourced from key regions such as Japan and Switzerland, which could lead to delayed osteoporosis diagnoses and increased equipment costs for healthcare facilities.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing incidence of osteoporosis is anticipated to drive the demand for bone densitometers. Osteoporosis, characterized by a decrease in bone density and strength leading to fragile bones, is attributed to factors such as low calcium intake, genetic disorders, and gastrointestinal surgery. Bone densitometers play a crucial role in calculating quantitative bone density through specific technologies and applications, aiding in the diagnosis and treatment of osteoporosis. With an estimated 1.5 million Americans experiencing osteoporosis-related fractures each year, costing $19 billion, as reported by Amgen in 2022, there is a heightened demand for bone densitometers. The global increase in osteoporosis cases is expected to propel the growth of the bone densitometer market.
The growing aging population is anticipated to drive the expansion of the bone densitometer market in the coming years. The term "aging population" refers to the increasing percentage and proportion of elderly individuals within the overall population. The aging population impacts the global economy, healthcare systems, and social support networks. Elderly individuals are more susceptible to developing osteoporosis, highlighting the need for early detection and prevention, as well as the significance of bone health and its implications for healthcare. Bone densitometry is a vital method for diagnosing and treating osteoporosis in older adults, with the potential to reduce healthcare costs while enhancing patient outcomes. For example, in January 2024, a report published by the Pew Research Center, a US-based organization, noted that the aging population is projected to reach 101,000 in 2024 and increase to 420,000 by 2054. Consequently, the rising aging population is propelling the growth of the bone densitometer market.
Technological advancements represent a prominent trend in the bone densitometer market, with major companies focusing on delivering advanced solutions to meet customer demands and enhance market positions. Companies are incorporating next-generation technologies, such as radiography, computed tomography, fluoroscopy, mammography, diffraction, 3D visualization, and modeling, into their bone densitometer products. For instance, Italian medical equipment manufacturer Echolight SPA offers an innovative radiation-free bone densitometry solution using Radiofrequency Echographic Multi Spectrometry (REMS) technology. REMS technology provides a radiation-free approach to assess the bone situation of the lumbar vertebral column and femoral neck, overcoming limitations of traditional techniques like DXA and QUS. This emphasis on technological innovation is driving the evolution of the bone densitometer market.
Major players in the bone densitometer market are strategically investing to enhance their capabilities, as exemplified by Zurcher Kantonalbank's investment in MEDIMAPS GROUP. Zurcher Kantonalbank made a significant investment of $20 million in Medimaps Group, a Swiss imaging software provider specializing in bone health evaluation using regular medical images. This investment was facilitated through Swisscanto Invest, Zurcher Kantonalbank's asset management arm. The financing round, led by Swisscanto Invest, also included participation from Swiss Entrepreneurs Fund, Swisscom Ventures, and Verve Ventures. In December 2021, Medimaps Group announced the successful raising of $20 million in institutional funding. This capital infusion aimed to support the development and commercialization of an artificial intelligence portfolio for bone health evaluation using routine medical images. The funds were earmarked for expanding the product line through the creation and launch of proprietary AI applications for bone health evaluation across the United States, Europe, Asia, and Latin America.
In April 2022, Newman Regional Health, a U.S.-based community hospital, forged a collaboration with Hologic to incorporate the Horizon DXA bone densitometry system into its healthcare offerings. This strategic partnership allowed Newman Regional Health to enhance its male and female health and well-being services. The Horizon DXA system, developed by Hologic, a U.S.-based manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products, is equipped with advanced imaging technology that provides excellent image quality and cutting-edge diagnostic tools. This system supports the early detection and treatment of osteoporosis, thereby contributing to improved healthcare outcomes for patients.
Major companies operating in the bone densitometer market include Diagnostic Medical Systems SA, GE Healthcare Technologies Inc., Hologic Inc., BeamMed Ltd., Demetech AB, Osteometer Meditech Inc., OSTEOSYS Corp., Trivitron Healthcare Private Limited, Swissray International Inc., MEDILINK Global Ltd., Xingaoyi Medical Equipment Co. Ltd., Echolight S.p.a, Eurotec Medical Systems srl, Scanflex Healthcare AB, Medonica Co. Ltd., CyberLogic Inc., Oscare Medical Oy, L'Acn Srl., Shenzhen Xray Electric Co. Ltd., YOZMA BMTech Co. Ltd., Nanoomtech Co. Ltd., FURUNO Electric Co. Ltd., ARTANN Laboratories Inc., StemLab Inc., CooperSurgical Inc., Medtronic PLC, Siemens AG, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd.
North America was the largest region in the bone densitometer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bone densitometer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The countries covered in the bone densitometer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The bone densitometer market consists of sales of central DEXA and peripheral DEXA. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bone Densitometer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bone densitometer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bone densitometer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bone densitometer market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.